Life Sciences
Life Sciences Law360 provides breaking legal news and analysis on the pharmaceutical and medical device industry. Coverage includes high-stakes litigation and policy developments that affect life sciences companies, as well as licensing deals, mergers, and other corporate transactions.
Sign up for a 7-day FREE trial today!
Latest News in Life Sciences
-
April 18, 2018
Hundreds Seek To Centralize NJ Taxotere Hair Loss Suits
Hundreds of women have called for centralized management of their New Jersey state actions alleging Sanofi-Aventis and other drug companies failed to adequately warn consumers about the risk of permanent hair loss from using the breast cancer drug Taxotere.
-
April 18, 2018
Fed. Circ. Affirms PTAB Ax Of Cialis, Adcirca Patents
The Federal Circuit on Wednesday affirmed two Patent Trial and Appeal Board inter partes review decisions that the asserted claims of patents owned by an Eli Lilly subsidiary covering the erectile dysfunction drug Cialis and pulmonary arterial hypertension drug Adcirca are invalid as obvious.
-
April 18, 2018
Ex-Pharma Staffing Exec Gets Noncompete Suit Tossed
An Illinois federal judge on Tuesday dismissed with prejudice a lawsuit seeking to enforce a noncompete agreement against the former director of Medix Staffing Solutions Inc.’s pharmaceutical and biotechnology staffing division, saying the contract is overly broad and unenforceable.
-
April 18, 2018
Deals Rumor Mill: Altice, Carl Icahn, Grail
The European Commission plans to fine Altice, Carl Icahn snapped up a less than 5 percent stake in Dell Technologies unit VMware, and Grail Inc. wants to raise $1 billion.
-
April 18, 2018
Pharmacy, PE Fund Owner Want Tricare FCA Suit Trashed
A Florida compounding pharmacy and its private equity fund owner on Tuesday urged a federal court to toss False Claims Act litigation accusing them of running a $68 million kickback scheme involving medically unnecessary prescriptions for Tricare beneficiaries, contending that the government's allegations are far too generalized.
Areas of Coverage
- AGENCIES
- U.S. Consumer Product Safety Commission
- U.S. Food and Drug Administration
- U.S. Patent and Trademark Office
- U.S. International Trade Commission
- POLICY & REGULATION
- Affordable Care Act
- Federal Food, Drug, and Cosmetic Act
- Antitrust and consumer protection controls
- Drug and medical device lobbying
- State and international life sciences legislation and regulation
- ENFORCEMENT
- Drug and medical device recalls
- Drug safety actions
- Pay-for-delay investigations
- Merger reviews
- LITIGATION
- Patent disputes, including
- Abbreviated New Drug Application litigation
- Section 301 cases
- Product safety suits over drugs and medical devices, including off-label marketing and failure-to-warn claims
- Consumer litigation and class actions
- Fraud and compliance suits
- Antitrust disputes
- Labor and employment suits
- Shareholder and corporate governance disputes
- Bankruptcy proceedings
- TRANSACTIONS
- Mergers, acquisitions, and joint ventures
- Share buybacks and stock splits
- Private equity deals
- Patent-licensing agreements
- PROFILES
- Personnel moves
- Profiles of life sciences practice groups
Readership
- Life sciences lawyers at top law firms
- Corporate counsel and compliance officers at Fortune 1000 companies
- Executives and attorneys in the drug, biotechnology, and medical device industries
- Information experts at law firms, agencies, and companies
- Policymakers at federal and state agencies
- Judges and court staff across the U.S.
- Professors, students, and library staff at every accredited law school in the U.S.
- Attorney and law firm marketing professionals